Stay updated on Amivantamab in Gastric Cancer Clinical Trial
Sign up to get notified when there's something new on the Amivantamab in Gastric Cancer Clinical Trial page.

Latest updates to the Amivantamab in Gastric Cancer Clinical Trial page
- Check6 days agoChange DetectedThe page's revision history now shows a new build version v3.6.6, replacing the previous v3.6.5.SummaryDifference0.1%

- Check13 days agoNo Change Detected
- Check20 days agoNo Change Detected
- Check27 days agoChange DetectedThe page now displays a generic error HTML indicating the record is unavailable, replacing the study content and attached documents. This prevents viewing the trial details until the issue is resolved.SummaryDifference17%

- Check41 days agoChange DetectedRevision label changed from v3.6.3 to v3.6.4, indicating a minor page update; no changes to study data, eligibility, or user-facing content are evident.SummaryDifference0.0%

- Check62 days agoChange DetectedThe site revision tag was updated from v3.6.2 to v3.6.3, indicating a new build of the ClinicalTrials.gov page.SummaryDifference0.0%

- Check69 days agoChange DetectedThe page now displays Revision: v3.6.2, replacing the previous Revision: v3.6.0. This update is a metadata release tag and does not change study data or content.SummaryDifference0.1%

- Check83 days agoChange DetectedNew help/navigation sections have been added (How to Read a Study Record, Common Questions, How to Join a Study) and the Intervention/Treatment label has been updated. The study's recruitment status is now shown as 'No longer looking for participants,' and a new revision entry 'Revision: v3.6.0' has been introduced.SummaryDifference0.5%

Stay in the know with updates to Amivantamab in Gastric Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Amivantamab in Gastric Cancer Clinical Trial page.